- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06149858
Ventral Mesh Hernioplasty : Laparoscopic Versus Open Sublay
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
A hernia usually happens in abdomen or groin, when one of your organs pushes through the muscle or tissue that contains it. Most hernias eventually will need surgical repair.
sublay mesh repair has the lowest recurrence and surgical site infection in open anterior abdominal hernia repair it is a perfect choice for the repair of ventral abdominal hernia the principles included two main steps: (1) mesh placement deep into the recti muscles and (2) mesh extension beyond the hernia defect.
Laparoscopic ventral hernia repair (LVHR) has established itself as a well-accepted option in the treatment of hernias. Clear benefits have been established regarding the superiority of LVHR in terms of fewer wound infections compared with open repairs. Meticulous technique and appropriate patient selection are critical to obtain the reported results.
• In the laparoscopic technique, a prosthetic mesh is inserted through a trocar into the abdominal cavity and fixed against the abdominal wall. After reducing the hernia contents, the hernia sac is left unresected, and most surgeons do not place additional sutures for closing the hernia orifice. A specific risk of laparoscopic hernia repair lies in freeing adhesions between intestine and abdominal wall, which may result in (sometimes unrecognised) bowel perforation . The mesh should overlap the hernia orifice by at least 5 cm and is anchored to the abdominal wall with tacks, transfascial sutures, or a combination of the two methods. In laparoscopic abdominal hernia repair, mesh placement methods are generally classified into intraperitoneal onlay mesh (IPOM), transabdominal abdominal preperitoneal (TAPP)
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: ahmed hussein
- Phone Number: 01091081032
- Email: ahmed.nazeir.1996@gmail.com
Study Contact Backup
- Name: Ibrahim Mostafa
- Phone Number: 01090526849
- Email: Ibrahim.mostafa@aun.edu.eg
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- All cases of midline ventral hernia fit for surgery
Exclusion Criteria:
- Surgically unfit cases
- Complicated hernia (obstructed ,irreducible, strangulated)
- incisional ,massive ,recurrent hernias
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: sublay
patients with ventral hernia operated as sublay mesh repair positioning of mesh under sheath
|
ventral hernia repair with mesh
|
|
Experimental: laparoscopic
patients with ventral hernia operated as laparoscopic repair positioning TAPP mesh
|
ventral hernia repair with mesh
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
recurrence rate
Time Frame: baseline
|
compare between laparoscopic ventral hernia repair and open sublay technique in how long the hernia take to occur again
|
baseline
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: hisham ryad
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ventral hernia repair
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ventral Hernia
-
Varazdin General HospitalCompletedIncisional Ventral Hernia | Recurrent Ventral HerniaCroatia
-
Anne Arundel Health System Research InstituteMedtronic - MITGCompletedGrade I Ventral Hernia | Grade II Ventral HerniaUnited States
-
Sofregen Medical, Inc.TerminatedVentral Hernia RepairUnited States
-
University Hospital, Strasbourg, FranceRecruitingVentral Hernia RepairFrance
-
Makassed General HospitalSuspended
-
GSVM Medical CollegeCompleted
-
Zaza DemetrashviliRecruitingLarge Midline Ventral HerniaGeorgia
-
Hvidovre University HospitalUniversity of CopenhagenCompleted
-
Hvidovre University HospitalCopenhagen University Hospital at HerlevCompleted
-
Distalmotion SAConfinisCompletedVentral Hernia RepairSwitzerland, Austria, France, Germany
Clinical Trials on hernioplasty
-
Groene Hart ZiekenhuisErasmus Medical CenterUnknownHernia, Inguinal | Unilateral Inguinal HerniaNetherlands
-
Services Hospital, LahoreCompletedParaumbilical HerniaPakistan
-
Sarawak General HospitalUnknownInguinal Hernia
-
Aesculap AGB.Braun Surgical SACompletedVentral Hernia | Abdominal Hernia | Abdominal Wall Defect | Fascial HerniaSpain
-
Assiut UniversityUnknown
-
Hospital PlatóCompleted
-
Assiut UniversityNot yet recruitingHernia, Inguinal
-
Assiut UniversityNot yet recruitingIncisional Hernia
-
Mansoura UniversityCompleted
-
Cirujanos la SerenaCompletedIndirect Inguinal HerniaChile